Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: A preliminary report

Psychopharmacology

Volumn 142, Issue 2, 1999, Pages 132-138

  Renshaw, Perry F ^a   Daniels, Sarah ^b   Lundahl, Leslie H ^b   Rogers, Veronica ^b   Lukas, Scott E ^b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CDP choline; Citicoline; Cocaine; Craving; Cytidine; Drug dependent; Human; Medication

Indexed keywords

CITICOLINE; COCAINE; DOPAMINE; PHOSPHOLIPID;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG SAFETY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WITHDRAWAL SYNDROME;

ADULT; CENTRAL NERVOUS SYSTEM; COCAINE-RELATED DISORDERS; CUES; CYTIDINE DIPHOSPHATE CHOLINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NOOTROPIC AGENTS; TASK PERFORMANCE AND ANALYSIS;

EID: 0032957749     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050871     Document Type: Article

References (40)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, D.C.
2. Ayuso JL, Saiz J (1977) Efecto protector del citidín-5-difosfato de colina sobre el defecto mnésico post-electrochoque. Munch Med Wochenschr (Spanish edn) 119:53-59
3. Babb SM, Appelmans KE, Renshaw PF, Wurtman RJ, Cohen BM (1996) Differential effect of CDP-choline on brain cystolic choline levels in younger and older subjects as measured by proton magnetic resonance spectroscopy. Psychopharmacology 127:88-94
4. Batki SL, Manfredi LB, Jacob P III, Jones RT (1993) Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Psychopharmacol 13:243-250
5. Carcassone M, LeTourneau JN (1979) Etude en double insu du Réxort en neurotraumatologie infantile. Vie Méd 12:1007
6. Chida N, Shimizu Y (1973) Biosynthesis of myelin lipids of cultured nervous tissues. Incorporation of choline and CDP-choline into myelin phospholipids. Tohoku J ExpMed 111: 41-49
7. Childress AR, Hole AV, Ehrman RN, Robbins SJ, McLellan AT, O'Brien CP (1993) Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr 137:73-95
8. 31P MR spectroscopy study. Magnet Res Med 35:658-663
9. Clark WM, Warach SJ, Pettigrew LC, Gammans RE, Sabounjian LA (1997) A randomized dose-response trial of citicoline in acute ischemic stroke patients. Neurology 49:671-678
10. Dackis CA, Gold MS (1985) Bromocriptine as treatment of cocaine abuse. Lancet 8483:1151-1152
11. Eberhardt R, Birbamer G, Gerstenbrand F, Rainer E, Traegner H (1990) Citicoline in the treatment of Parkinson's disease. Clin Ther 12:489-495
12. Ehrman RN, Robbins SJ, Childress AR, O'Brien CP (1992) Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology 107:523-529
13. First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured clinical interview for DSM-IV axis I disorders - patient edition (SCID-I/P, vers 2.0). Biometrics Research Department, New York
14. Goas JY, Bastard J, Missoune A (1980) Bilan a 90 jours du traitement des accidents vasculaires cérébraux par la CDP-choline, a propos d'un essai en double insu. Symposium International: Souffrance Cérébrale et Précurseurs des Phospholipides, Paris
15. Kaufman MJ, Levin JM, Ross MH, Lange N, Rose SL, Kukes TJ, Mendelson JH, Lukas SE, Cohen BM, Renshaw PF (1998) Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA 279: 376-380
16. Kennedy EP, Weiss SB (1956) The function of cytidine coenzyme in the biosynthesis of phospholipids. J Biol Chem 222:193-214
17. Kleber HD, Gawin FH (1984) Cocaine abuse: a review of current and experimental treatments. In: Grabowski J (ed) Cocaine: pharmacology, effects, and treatment of abuse NIDA Res. Monogr. 50, DHHS Publi No. (ADM) 84-1326, US Government. Printing Office, Washington, D.C., pp 111-129
18. Levin JM, Holman BL, Mendelson JH, Teoh SK, Garada B, Johnson KA, Springer S (1994) Gender differences in cerebral perfusion in cocaine abuse. J Nucl Med 35:1902-1909
19. Little KY, Patel UN, Clark TB, Butts JD (1996) Alteration of brain dopamine and serotonin levels in cocaine users: a preliminary report. Am J Psychiatry 153:1216-1218
20. Lukas SE (1993) Advanced electrophysiological imaging techniques for studying drug effects. In: London, ED (ed) Imaging drug action in the brain. CRC Press, Boca Raton, pp 389-404
21. Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245-258
22. Martinet M, Fonlupt P, Pacheco H (1978) Interaction of CDP-choline with synaptosomal transport of biogenic amines and their precursors in vitro and in vivo in the rat corpus striatum. Experientia 34:1197-1199
23. Martinet M, Fonlupt P, Pacheco H (1979) Effects of cytidine-5′-diphosphocholine on norepinephrine, dopamine and serotonin synthesis in various regions of the rat brain. Arch Int Pharmacodyn 239:52-56
24. Miller EN, Satz P, Visscher BV (1991) Computerized and conventional neuropsychological assessment of HIV-1 infected homosexual men. Neurology 41:1608-1616
25. Moriyama M, Tsukumo T, Nakagawa Y (1967) Effects of CDP-choline on head injury. Gendai no Rinsho 1:114-120
26. Pulvirenti L, Koob GF (1994) Dopamine receptor agonists, partial agonists and psychostimulant addiction. Trends Pharmacol Sci 15:374-379
27. Ruggieri S, Zamponi A, Casacchia M, Agnoli A (1976) Effetti terapeutici della citicolina (citidin-difosfo-colina) nella sindrome parkinsoniana. Cl Tera 78:515-525
28. Saligaut C, Daoust M, Moore N, Chretien P, Boismare F (1984) Cature de dopamine striatale chez le rat : effets d'une hypoxie hypobare aigue et/ou d'un traitement oral par la cytidine diphosphocholine. Circ Metab Cerv 2:33-42
29. Salvadorini F, Galeone F, Nicotera M, Ombrato M, Saba P (1975) Clinical evaluation of CDP-choline (Nicholin®): efficacy as antidepressant treatment. Curr Ther Res 18:513-520
30. Secades JJ, Frontera G (1995) CDP-choline: pharmacological and clinical review. Methods Find Clin Pharmacol 17 [Suppl B]: 1-54
31. SPSS, Inc. (1994) SPSS Advanced Statistics™ 6.1. SPSS, Chicago
32. Strickland A, Mena I, Villanueva-Meyer J, Tabbarah M, Miller B (1991) Long term effect of cocaine abuse on brain perfusion: assessment with Xe-133 rCBF and Tc-99m-HMPAO. J Nucl Med 32:1021
33. Tiffany ST, Singleton E, Haertzen CA, Henningfield JE (1993) The development of a cocaine craving questionnaire. Drug Alcohol Depend 34:19-28
34. Tumeh SS, Nagel JS, English RJ, Moore M, Holman BL (1990) Cerebral abnormalities in cocaine abusers: demonstration by SPECT perfusion scintigraphy. Radiology 176:821-824
35. 11C] WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 18:419-427
36. Volkow ND, Mullani N, Gould KL, Adler S, Krajewski K (1988) Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br J Psychiatry 152:641-648
37. Walsh SL, Preston KL, Sullivan JT, Fromme R, Bigelow GE (1994) Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Psychopharmacol 14:396-407
38. Weiss GB (1995) Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicholine. Life Sci 56:637-660
39. Weiss RD (1988) Relapse to cocaine abuse after initiating desipramine treatment. J AmMed Assoc 260:2545-2546
40. Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, Adams VI, Smialek J, Anderson WR, Shannak K, Deck J, Niznik HB, Kish SJ (1996) Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol 40:428-439